Literature DB >> 16340092

GammaKnife surgery: safety and the identity of users.

David Dinka1, James M Nyce, Toomas Timpka.   

Abstract

In this study we investigated safety-related usability issues of an advanced medical technology, a radiosurgery system. We were interested in which criteria are important for users when a system's usability and safety is to be improved. The data collection was based on interviews and observations at three different sites where the Leksell GammaKnife is used. The analysis was qualitative. The main finding was that the user's identity or professional background has a significant impact both on how he or she views his or her role in the clinical setting, and on how he or she defines what improvements are necessary and general safety issues. In fact, the opinion even of users experienced in safety-related problems was highly influenced by how they related to the technology and its development. None of the users actually considered Leksell GammaKnife as lacking in safety, instead, their assessment was directed towards potential future system improvements. Our findings suggest that the importance of user identity or professional background cannot be neglected during the development of advanced technology. They also suggest that the user feedback should always be related to user background and identity in order to understand how important different issues are for particular users.

Mesh:

Year:  2005        PMID: 16340092

Source DB:  PubMed          Journal:  Technol Health Care        ISSN: 0928-7329            Impact factor:   1.285


  2 in total

1.  Adding value with 3D visualization and haptic forces to radiosurgery--a small theory-based, quasi-experimental study.

Authors:  David Dinka; James N Nyce; Toomas Timpka; Kristina Holmberg
Journal:  J Med Syst       Date:  2006-08       Impact factor: 4.460

2.  The social process of escalation: a promising focus for crisis management research.

Authors:  Johan Bergström; Sidney Dekker; James M Nyce; Isis Amer-Wåhlin
Journal:  BMC Health Serv Res       Date:  2012-06-15       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.